We use cookies to store user settings and preferences on this site. We do not preserve any personal data in cookies.
search
Antibody-Based Inhibition of Uropathogenic E. coli Adhesion

The technology offers innovative antibody compositions that target the FimH adhesin of uropathogenic E. coli, preventing bacterial adhesion and biofilm formation.

TBD
Bikunin Biomimetic with Anti-Inflammatory and Antiviral Activity

The solution is a serine protease inhibitor, bikunin, that plays a role in controlling the early immune response to Influenza A virus.

TBD
Computationally Designed Inhibitor for Epstein-Barr Virus BHRF1 Protein

The technology is a novel polypeptide designed to inhibit the Epstein-Barr virus BHRF1 protein, inducing apoptosis in infected cells and offering a potential therapeutic approach for Epstein-Barr-related diseases and cancers.

TBD
Enhanced Influenza Hemagglutinin Binders

This technology offers innovative polypeptides that bind with high affinity to influenza hemagglutinin, offering potential applications in treatment, diagnosis, and prevention of influenza.

TBD
IgG3 Spike Protein Binding Assay

The innovation offers a fast, inexpensive single-tier assay that offers clinical utility as a screening method to identify patients who have SARS-CoV-2 immunity based on the presence of spike-binding, neutralizing IgG3 antibodies against SARS-CoV-2

TBD
Novel Nanoparticle Immunogens for Influenza Vaccines

This technology offers a new approach to influenza vaccines using computationally designed nanoparticle immunogens that elicit potent, neutralizing antibodies against influenza viruses.

TBD
Repurposing Combinations of Approved Drugs for Viral Outbreak Response and Readiness

The collection of technologies offers a simple yet powerful method for identifying combinations of previously FDA approved drugs with synergistic activity against viral infections. The technology is available for immediate use in preparation IND-enabling studies in high impact viral disease areas.

TBD
Targeted Protein Degradation in Bacteria Contributes to Antibiotic Efficacy

The solution is a method to develop new antibiotic proteolysis targeting chimeras (PROTACs) that target proteins of interest for degradation in bacteria to counteract antibiotic resistance.

TBD
Treponema Pallidum-Specific Aptamers for Syphilis Diagnostics

The solution is the development of Treponema pallidum-specific aptamers to be used in accurate point-of-care diagnostic assays for syphilis.

TBD
Category VIEW ALL
chevron_right
chevron_right
chevron_right
chevron_right
chevron_right
chevron_right
chevron_right
chevron_right
chevron_right
chevron_right
chevron_right